SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Romania
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Institutul Pasteur

Main Activities: Pharmaceutical and Medicine Manufacturing

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Societatea Nationala

Headquarters
333, Calea Giulesti ; BUCURESTI; Bucharest; 60269
Status: Non-Listed
Legal Form: Public Limited Company
Operational Status: Operational
CUI: 00472593
Total Employees: 219

Tel: 00 40-21-220.69.15

Company Description

The Pasteur Institute of Bucharest is the Romanian research, manufacture and distribution company for veterinary products, serving animal welfare, public health and environment protection. The Institute was founded in 1895 within the Veterinary Faculty as the Institute for Animal Vaccines.
In 2002, over 90% stake is bought by the Romanian-American company A&S International 2000 SRL, the Romanian State keeping only the golden share for the research and diagnosis activity.
In 2002, Pasteur
More

Company Analysis

According to the Individual - Non-Audited financial statement for the Year of 2011, total net operating revenues decreased with -41.52%, from RON 25,567,522 to RON 14,952,086 . Operating Results increased from RON -61,997,104 to RON 94,008 . The results of the period reached RON 63,947 at the end of the period against RON -62,200,290 last year. Return on equity (Net income/Total equity) went from -63.14% to 0.07%, the Return On Asset (Net income / Total Asset) went from -56.41% to 0.06% and the Net Profit Margin (Net Income/Net Sales) went from -243.28% to 0.43% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 12.88% compared to 11.94% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.59 to 1.65 when compared to the previous year.

Key Executives

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

110,687,569

111,565,675

Current Assets

XX,XXX,XXX

XX,XXX,XXX

Total Liabilities

XX,XXX,XXX

XX,XXX,XXX

Shareholders Equity

XX,XXX,XXX

XX,XXX,XXX

Current Liabilities

XX,XXX,XXX

XX,XXX,XXX

* All the accounts are in RON.
Income Statement

Total Operating Revenue

XX,XXX,XXX

X,XXX,XXX

Operational Profit (Loss)

XX,XXX

XXX,XXX

Net Profit (Loss)

XX,XXX

XXX,XXX

* All the accounts are in RON.
Ratios
Profitability Ratios

Return on Assets (ROA)

X.XX%

X.XX%

Annualised Return on Assets (ROA)

X.XX%

X.XX%

Return on Equity (ROE)

X.XX%

X.XX%

Annualised Return on Equity (ROE)

X.XX%

X.XX%

Return on Sales (ROS)

X.XX%

XX.XX%

Return on Capital

X.XX%

X.XX%

Gross Profit Margin

XX.XX%

XX.XX%

Operating Profit Margin

X.XX%

X.XX%

Efficiency Ratios

Accounts Receivable Turnover

X.XXx

X.XXx

Inventory Turnover

X.XXx

X.XXx

Current asset turnover

X.XXx

X.XXx

Fixed-asset turnover

X.XXx

X.XXx

Asset Turnover

X.XXx

X.XXx

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

XX,XXX

XXX,XXX

EBITDA

X,XXX,XXX

X,XXX,XXX

Bookvalue (BV)

XX,XXX,XXX

XX,XXX,XXX

Net Cash

-XX,XXX,XXX

-XX,XXX,XXX

Liquidity Ratios

Current Ratio

XXX.XX%

XXX.XX%

Quick ratio

XXX.XX%

XX.XX%

Doom's day ratio

X.XX%

X.XX%

Leverage Ratios

Leverage ratio

XXX.XX%

XXX.XX%

Interest Coverage Ratio

XXX.XX%

X.XX%

Debt to equity

XX.XX%

XX.XX%

Debt to total assets

XX.XX%

XX.XX%

Long Term Debt to Capital

X%

X.XX%